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ABSTRACTS 1A 
XANE REDUCTION AND/OR 
IAE ~EP~~~S~ON INJURY 
PREVEVT 
Katsuya Akashi, Anthony DiPaula, Lewis 
Hopkins Medical Institutions, Baltimore, MD 
Thromboxane synthetase inhibitors (TXSI) or thromboxane 
receptor antagonists (T ) reduce myocardial infarct size 
end neutrophil infiltra on when given before ischemia or 
in early ischemia. TXSI shunt cyclooxygenase products to 
prostacyclin (PG12) while TXRA increase the ratio of PGIP 
to thromboxane activity. An increase in the ratio of PGI2 
to thromboxane activity could directly inhibie neutrophil 
activation by increasing intracellular LAMP, resulting in 
less myocardial damage. To see if these agents are also 
effective when given at the eime of reperfusion, we gave 
a TXSI (CGS 13080, 1 mg/kg bolus and 0.3 mg/kg/hr IV; 
N-10). a TXRA (SQ 30741, lmg,&g bolus and lmg/kg/hr IV; 
N-lo), both (N-l), or placebo (N-15) 15 minutes prior to 
reperfusion in dogs undergoing 90 minutes of anterior 
descending coronary artery occlusion and 
reperfusion. TXSI reduced mean thromboxane 
venous blood from 134 
6-keeo prostaglandin 0 7998 p&/ml (pc.001). 
era1 blue and infarct 
flow (measured by microspheres). 
fail to prevent reperfusion injury when given at the end 
of ischemia. An increase in PGIP activity at ‘this time may 
be ineffective because of an inability to inhibit neutro- 
phils already activated by prolonged ischemia. 
CTIVITY IN CHRONIC LEFT 
&J DavLes, Sally E Jordan, 
RoyaP Fsee Hospital, London, 
To investigate tPne contribution of bronchial 
erreactivity to exercise limitation in chronic 
failure (CMF) , 10 patients (pts) (mean age 60 
ps, range 39-72) in NYHA class II-III with no 
clinical evidence of airflow obstruction 
underwent maximal symptom-limited treadmill 
exercise testing wit respiratory gas analysis. 
Pts exercised immediately following nebulised 
placebo(P), 5w salbutamol(S), 
iurn( given over 15 minuOfs 
4ooug 
in a 
double-blinded manner. Resting 
FEVJFVC! was 2.7+/-0.6 l/3.5+/-0.6 1 (85% and 81% 
predicted respectively). Peak expiratory flab 
rates (PEFR) wer measured at rest, post- 
nebuliser (PN) and ost-exercise (PE): 
REST IPN Ez 
P 493+/-10% 4ao+/-90 497+/-96 
S 489+/-100 514+/-89 ** 534+/-90 * 
533+/-86 ** 
Thus, 
or at a VOz of 1.0 ml/min/kg. 
bronchodilatation with nebulised S 
increases maximal oxygen consumptior on exercise 
at krsnchial Ryperreactivity may 
limit exercise tolerance in CNF. 
FAI 
load and afterload Is beneficial for the 
gesttve heart failure. Dn this study, we 
esfects of thermal vasodi lation by hot 
congestive heart fallure. (Subjects 
8 were IQ p wl th di lated 
Ischmic card1 opathy. H-5 was 
reduced and pre-eject Ion period 
even 3 hours after H-B. After one month, NM44 grading 
slgnlflcant ly by the continuation of H-B I 2 times /day). 
la nor the aggravetlon of the s 
ter M-B: 24,+12* IBt 6*+ 3.6tO.5 
(30 mln) *=pa0.05 vs. control 
Its and clinical features in pts with 
roved after H-8, probably due to the 
oad by therm! vasodi 
vesodilator PheraDy of 
